{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:17:05Z","timestamp":1770999425285,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T00:00:00Z","timestamp":1350864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Only few studies have assessed safety of in utero exposure to glatiramer acetate (GA). Following a previous study assessing the safety of interferon beta (IFNB) pregnancy exposure in multiple sclerosis (MS), we aimed to assess pregnancy and fetal outcomes after in utero exposure to GA, using the same dataset, with a specific focus on the risk of spontaneous abortion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>We recruited MS patients, prospectively followed-up in 21 Italian MS Centres, for whom a pregnancy was recorded in the period 2002\u20132008. Patients were divided into 2 groups: drug-exposed pregnancies (EP: suspension of the drug less than 4 weeks from conception); non-exposed pregnancies (NEP: suspension of the drug at least 4 weeks from conception or never treated pregnancies). All the patients were administered a structured interview which gathered detailed information on pregnancy course and outcomes, as well as on possible confounders. Multivariate logistic and linear models were used for treatment comparisons.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Data on 423 pregnancies were collected, 17 were classified as EP to GA, 88 as EP to IFNB, 318 as NEP. Pregnancies resulted in 16 live births in the GA EP, 75 live births in the IFNB EP, 295 live births in the NEP. GA exposure was not significantly associated with an increased risk of spontaneous abortion (OR\u2009=\u20090.44;95% CI 0.044-4.51;p\u2009=\u20090.49). Mean birth weight and length were not significantly different in pregnancies exposed to GA than in non exposed pregnancies (p\u2009=\u20090.751). The frequency of preterm delivery, observed in 4 subjects exposed to GA (25% of full term deliveries), was not significantly higher in pregnancies exposed to GA than in those non exposed (p\u2009&gt;\u20090.735). These findings were confirmed in the multivariate analysis. There were neither major complications nor malformations after GA exposure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Data in our cohort show that mother\u2019s GA exposure is not associated with a higher frequency of spontaneous abortion, neither other negative pregnancy and fetal outcomes. Our findings point to the safety of in utero GA exposure and can support neurologists in the therapeutic counselling of MS women planning a pregnancy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2377-12-124","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T10:14:25Z","timestamp":1350900865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study"],"prefix":"10.1186","volume":"12","author":[{"given":"Marta","family":"Giannini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Portaccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahia","family":"Hakiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Past\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Razzolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Piscolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"De Giglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Pozzilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damiano","family":"Paolicelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Trojano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Giovanna","family":"Marrosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Patti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"La Mantia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Mancardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Solaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Totaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosaria","family":"Tola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Lugaresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Moiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Comi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Pia","family":"Amato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,22]]},"reference":[{"key":"632_CR1","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1212\/WNL.0b013e3181fd62bb","volume":"75","author":"MP Amato","year":"2010","unstructured":"Amato MP, Portaccio E, Ghezzi A, et al: Pregnancy and fetal outcomes after interferon-beta exposure in multiple sclerosis. Neurology. 2010, 75: 1794-1802. 10.1212\/WNL.0b013e3181fd62bb.","journal-title":"Neurology"},{"key":"632_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/1352458510394610","volume":"17","author":"M Sandberg-Wollheim","year":"2011","unstructured":"Sandberg-Wollheim M, Alteri E, Moraga MS, Kornmann G: Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy. Mult Scler. 2011, 17: 423-430. 10.1177\/1352458510394610.","journal-title":"Mult Scler"},{"key":"632_CR3","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1471-0528.2011.02931.x","volume":"118","author":"A Finkelsztejn","year":"2011","unstructured":"Finkelsztejn A, Brooks JB, Paschoal FM, Fragoso YD: What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG. 2011, 118: 790-797. 10.1111\/j.1471-0528.2011.02931.x.","journal-title":"BJOG"},{"key":"632_CR4","volume-title":"The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis. Clin Neurol Neurosurg","author":"YD Fragoso","year":"2012","unstructured":"Fragoso YD, Boggild M, Macias-Islas MA, et al: The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis. Clin Neurol Neurosurg. 2012"},{"key":"632_CR5","first-page":"271","volume":"11","author":"T Chard","year":"1989","unstructured":"Chard T: Interferon in pregnancy. J Dev Physiol. 1989, 11: 271-276.","journal-title":"Interferon in pregnancy. J Dev Physiol"},{"key":"632_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1177\/1352458509106543","volume":"15","author":"C Weber-Schoendorfer","year":"2009","unstructured":"Weber-Schoendorfer C, Schaefer C: Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study. Mult Scler. 2009, 15: 1037-1042. 10.1177\/1352458509106543.","journal-title":"Mult Scler"},{"key":"632_CR7","first-page":"A60","volume":"60","author":"PK Coyle","year":"2003","unstructured":"Coyle PK, Johnson K, Pardo L, Stark Y: Pregnancy outcomes in patients with multiple sclerosis treated with glatiramer acetate (Copaxone). Neurology. 2003, 60: A60-","journal-title":"Neurology"},{"key":"632_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1590\/S0004-282X2009000400015","volume":"67","author":"YD Fragoso","year":"2009","unstructured":"Fragoso YD, Finkelsztejn A, Comini-Frota ER, et al: Pregnancy and multiple sclerosis: the initial results from a Brazilian database. Arq Neuropsiquiatr. 2009, 67: 657-660. 10.1590\/S0004-282X2009000400015.","journal-title":"Arq Neuropsiquiatr"},{"key":"632_CR9","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1007\/s00415-010-5652-y","volume":"257","author":"HJ Salminen","year":"2010","unstructured":"Salminen HJ, Leggett H, Boggild M: Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. J Neurol. 2010, 257: 2020-2023. 10.1007\/s00415-010-5652-y.","journal-title":"J Neurol"},{"key":"632_CR10","first-page":"969","volume":"24","author":"YD Fragoso","year":"2010","unstructured":"Fragoso YD, Finkelsztejn A, Kaimen-Maciel DR, et al: Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series. CNS Drugs. 2010, 24: 969-976.","journal-title":"CNS Drugs"},{"key":"632_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G, et al: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001, 50: 121-127. 10.1002\/ana.1032.","journal-title":"Ann Neurol"},{"key":"632_CR12","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983, 33: 1444-1452. 10.1212\/WNL.33.11.1444.","journal-title":"Neurology"},{"key":"632_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2741\/2737","volume":"13","author":"R Raghupathy","year":"2008","unstructured":"Raghupathy R, Kalinka J: Cytokine imbalance in pregnancy complications and its modulation. Front Biosci. 2008, 13: 985-994. 10.2741\/2737.","journal-title":"Front Biosci"},{"key":"632_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000242165","volume":"48","author":"JC Challier","year":"1985","unstructured":"Challier JC, Guerre-Millo M, Nandakumaran M, Gerbaut L: d'Athis P. Clearance of compounds of different molecular size in the human placenta in vitro. Biol Neonate. 1985, 48: 143-148. 10.1159\/000242165.","journal-title":"Biol Neonate"},{"key":"632_CR15","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1128\/AAC.37.6.1232","volume":"37","author":"A Waysbort","year":"1993","unstructured":"Waysbort A, Giroux M, Mansat V, Teixeira M, Dumas JC, Puel J: Experimental study of transplacental passage of alpha interferon by two assay techniques. Antimicrob Agents Chemother. 1993, 37: 1232-1237. 10.1128\/AAC.37.6.1232.","journal-title":"Antimicrob Agents Chemother"},{"key":"632_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jneuroim.2003.08.001","volume":"144","author":"P Putheti","year":"2003","unstructured":"Putheti P, Soderstrom M, Link H, Huang YM: Effect of glatiramer acetate (Copaxone) on CD4\u2009+\u2009CD25high T regulatory cells and their IL-10 production in multiple sclerosis. J Neuroimmunol. 2003, 144: 125-131. 10.1016\/j.jneuroim.2003.08.001.","journal-title":"J Neuroimmunol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-12-124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-12-124\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-12-124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-12-124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:12:40Z","timestamp":1630527160000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-12-124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,22]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["632"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-12-124","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,22]]},"assertion":[{"value":"16 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"124"}}